Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease - Poll - MDSpire

Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease

  • By

  • Nienke P. M. Wassenaar

  • Koen C. van Son

  • Bas Voermans

  • Kirsi M. A. van Eekhout

  • Marian A. Troelstra

  • Stan Driessen

  • Anne Line Mak

  • Julia J. Witjes

  • Anne-Marieke van Dijk

  • Veera Houttu

  • Diona Zwirs

  • Elizabeth Shumbayawonda

  • Max Nieuwdorp

  • Michail Doukas

  • Joanne Verheij

  • Aart J. Nederveen

  • Oliver J. Gurney-Champion

  • Adriaan G. Holleboom

  • March 28, 2026

  • 0 min

Share

Original Source(s)

Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease

  • by Nienke P. M. Wassenaar, Koen C. van Son, Bas Voermans, Kirsi M. A. van Eekhout, Marian A. Troelstra, Stan Driessen, Anne Line Mak, Julia J. Witjes, Anne-Marieke van Dijk, Veera Houttu, Diona Zwirs, Elizabeth Shumbayawonda, Max Nieuwdorp, Michail Doukas, Joanne Verheij, Aart J. Nederveen, Oliver J. Gurney-Champion, Adriaan G. Holleboom

  • March 28, 2026

Related Content

Diurnal Light Exposure and Rest-Activity Rhythms in Relation to MASLD: Insights From 2 Nationwide Cohort Studies

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Discover the power of gut microbiome tests for wellness and longevity